Skip to content

Keratoconus: a French view

Listen to two French keratoconus experts discuss the latest treatments for this corneal disease and the evidence to support their use in this podcast from the The European Society of Cataract & Refractive Surgeons (ESCRS).

Why you are paying so much for surgery

ABC Four Corners produced this program Mind the Gap on why you are paying such high out-of-pocket expenses for surgery. A great guide to dealing with surgeons before surgery. Watch the program

Medicare rebate for corneal cross-linking

Thousands of Australians with keratoconus will benefit from a Medicare rebate of $1,200 for corneal collagen cross-linking as first line treatment to stop disease progression. read more    

First results from Australian Crosslinking Registry

The head of the Australian Crosslinking Registry, Professor Stephanie Watson, presented the latest results from the registry on crosslinking at meetings in Melbourne and Sydney. The full video of her presentation can be viewed here Her slideshow presentation (pdf format) can be downloaded below Professor Watson Nov 2017 talk

Cross-linking stabilises keratoconus

Optometry Australia News   Collagen corneal cross-linking appears to stabilise keratoconus in patients who undergo the procedure, according to early results of a world-first keratoconus registry based in Australia. Ophthalmologist Professor Stephanie Watson has completed initial analysis of data from 1,062 keratoconic patients in Australia and New Zealand including adults, teenagers and children who had

Read More

Is Cross-linking at a Crossroads?

FDA-approved corneal collagen cross-linking is barely a year old (in the United States). The Avedro KXL UV system, along with Photrexa and Photrexa Viscous, is approved for patients aged 14 and up with progressive keratoconus or post-surgical ectasia. After years of commercial use abroad, this long-awaited therapeutic option has the potential to halt vision loss

Read More

Recent Innovations in Collagen Corneal Cross-linking; a Mini Review

1. INTRODUCTION Corneal cross-linking (CXL) was introduced in the late 1990s by Seiler et al. [1, 2]. Until that time the conservative therapeutic approach of Keratoconus and other corneal ectatic diseases, involved mostly the fitting of hard contact lenses as an improvement of corrected visual acuity and as a mean to halt the progression through corneal adaptation on

Read More